BLACK DIAMOND THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $0 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2022-03-17
- BLACK DIAMOND THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-06-30 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $16.00K.
- BLACK DIAMOND THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $16.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | ||
| 2020-12-31 | $16.00K 10-K · filed 2022-03-17 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $16.00K 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $16.00K 10-Q · filed 2021-11-08 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $0.00 10-Q · filed 2020-08-11 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |